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Abstract
Background: Total hip joint replacement (THR) is a high volume, effective intervention for hip
osteoarthritis (OA). However, indications and determinants of outcome remain unclear. The
'EUROHIP consortium' has undertaken a cohort study to investigate these questions. This paper
describes the variations in disease severity in this cohort and the relationships between clinical and
radiographic severity, and explores some of the determinants of variation.
Methods: A minimum of 50 consecutive, consenting patients coming to primary THR for primary
hip OA in each of the 20 participating orthopaedic centres entered the study. Pre-operative data
included demographics, employment and educational attainment, drug utilisation, and involvement
of other joints. Each subject completed the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC – Likert version 3.1). Other data collected at the time of surgery
included the prosthesis used and American Society of Anaesthesiologists (ASA) status. Pre-
operative radiographs were read by the same three readers for Kellgren and Lawrence (K&L)
grading and Osteoarthritis Research Society International (OARSI) atlas features. Regression
analyses were carried out.
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BMC Musculoskeletal Disorders 2009, 10:19 http://www.biomedcentral.com/1471-2474/10/19Results: Data from 1327 subjects has been analysed. The mean age of the group was 65.7 years,
and there were more women (53.4%) than men. Most (79%) were ASA status 1 or 2. Reported
disease duration was 5 years or less in 69.2%. Disease in other joint sites was common.
Radiographs were available in 1051 subjects and the K&L grade was 3 or 4 in 95.8%. There was
much more variation in clinical severity (WOMAC score); the mean total WOMAC score was 59.2
(SD 16.1). The radiographic severity showed no correlation with WOMAC scores.
Significantly higher WOMAC scores (worse disease) were seen in older people, women, those with
obesity, those with worse general health, and those with lower educational attainment.
Conclusion: 1. Clinical disease severity varies widely at the time of THR for OA.
2. In advanced hip OA clinical severity shows no correlation with radiographic severity.
3. Simple scores of pain and disability do not reflect the complexity of decision-making about who 
should have a THR.
Background
Total hip replacement (THR) is an effective and cost-effec-
tive procedure for people with severe hip osteoarthritis
(OA), unresponsive to conservative therapy [1,2]. It has
become a high volume procedure throughout Europe,
and annual rates continue to rise [2,3].
It is generally accepted that the indications for THR are
pain and disability in spite of the use of non-surgical inter-
ventions such as education, drugs, walking aids and phys-
ical therapy [4]. However, it is not clear how severe the
pain or disability needs to be before surgery should be
undertaken, or when in the course of OA it is most appro-
priate to perform a THR. Economic modelling [5], some
outcome studies [6] and patient views [7] suggest that it
might be appropriate to perform surgery early on, before
the condition gets too severe. However, doctors tend to be
cautious about the use of a potentially dangerous and irre-
versible intervention too early, particularly because of evi-
dence that it is not universally successful [8] and the
accumulating risk with time of late prosthesis loosening
necessitating further, more complex surgery. The potential
implications of operating relatively early or late in the
course of the disease are large, as this could have massive
effects on the volume of surgery undertaken, as well as on
outcomes.
There have been a number of attempts to develop indica-
tions for THR through consensus procedures [9], appro-
priateness criteria [10], and criteria for the prioritisation
of patients waiting for a THR [11,12]. However, the result-
ing publications have done little more than emphasise the
importance of pain and physical disability, and they strug-
gle to take account of other factors that affect surgical deci-
sion making, such as co-morbidities, individual values
and aspirations, and psycho-social circumstances. Fur-
thermore, they do not address the issues of relative risk of
complications or of a poor outcome, or how these might
be affected by variations in THR indications.
The 'EUROHIP' consortium has been addressing the cur-
rent debate on the utilisation and timing of THR, by stud-
ying the indications for primary hip replacement [13,14],
and the process of hip replacement in the different centres
involved [15]. In addition, the group has developed a
cohort of people undergoing primary hip replacement for
primary OA. The overall aims of the 'EUROHIP' cohort
study are threefold: 1) to describe the amount of variation
in disease severity at the time of primary THR in Europe;
2) to look for determinants of any variation; 3) to exam-
ine the effects of variations and their determinants on
short-term (one year) patient centred outcomes. In this
paper we report on the first two of these aims – describing
the cohort and the variations in disease severity observed
at the baseline assessment, and exploring some of the
determinants of variations in pre-operative disease sever-
ity.
Methods
Participating centres and patients
The 'EUROHIP' consortium includes 20 orthopaedic cen-
tres in 12 different European countries. The overall design
was endorsed by representatives from each centre in 2002.
It was agreed that we would recruit a large multi-centre
cohort of patients undergoing primary THR willing and
able to complete self-administered questionnaires record-
ing demographic variables and pre-operative levels of
pain, stiffness, mobility and quality of life (using stand-
ard, validated questionnaires) as well as their expectations
of the operation. One year after surgery they would be
sent a similar questionnaire in the post. In addition, we
agreed to obtain pre-operative radiographs and to record
data about the operative procedure, including the type of
prosthesis used. Inclusion criteria included a diagnosis ofPage 2 of 12
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informed consent; exclusion criteria included causes of
hip disease other than OA, severe mental illness or
dementia, and patients unwilling or unable to take part in
the study.
Data collection
Each centre obtained local ethical approval, if required.
The study protocol and data collection forms were
designed in Bristol, UK and Ulm, Germany by the study
PIs (PAD and KD) and the study co-ordinator (SW). The
patient questionnaire was piloted for acceptability in Bris-
tol and modified accordingly before being sent to Ulm for
translation and distribution. Questionnaires were sent to
each centre for translation and returned for checking
before printing and distribution with a set of instructions.
All data forms included the birth year and initials of the
patient, as well as a centre ID and an individual patient
number, to ensure unique identification while maintain-
ing patient anonymity. Full identification records of all
patients were kept separately in each centre. Completed
questionnaires were photocopied locally and then
returned to Bristol, where the database was constructed.
Prior to surgery, patients completed a questionnaire about
age, sex, home circumstances, employment, education,
current medications, duration of pain in the hip to be
replaced and problems in other joints. In addition, they
completed the WOMAC [16] and EQ5D [17] question-
naires (the EQ5D data has not been included in any of the
analyses presented below).
The Western Ontario and McMaster Universities 
(WOMAC) OA Index
The WOMAC index (version 3.1) was used to assess the
severity of symptoms. This consists of 24 items in 3 sub-
scales: pain (5 items), stiffness (2), and physical function
(17) [16]. Component items are measured on a 5-point
Likert scale with higher scores indicating greater symptom
severity (0 = none, 1 = slight, 2 = moderate, 3 = severe, and
4 = extreme). Missing data were treated as follows: if ≥ 2
pain, both stiffness, or ≥ 4 physical function items were
not completed, the items were regarded as invalid, and the
subscale score not calculated; where 1 pain, 1 stiffness, or
1–3 physical function items were missing, the average
value for the subscale was used in place of the missing
item. A total score was calculated for each subscale, and a
normalised score (0 indicating no symptoms and 100
indicating extreme symptoms) then calculated for each
subscale, by summing up the total score of each subscale,
multiplying it by 100, and dividing by the possible maxi-
mum score for the scale. A total score out of 96 was cre-
ated by combining the 3 subscales. This was then
converted into a normalised score out of 100, as described
in the WOMAC user's handbook.
The surgical teams were asked to complete a form record-
ing the patient's height and weight (from which BMI was
calculated), side of surgery, duration of arthritis, date
wait-listed and date of surgery. The form also asked for
prosthesis type, ASA status – a standard measure of fitness
for surgery, scored in this study from 1 (normal, healthy)
to 4 (life-threatening systemic disease) [18].
The Kellgren and Lawrence (K&L) Radiographic scores
The K&L score was used to assess structural disease sever-
ity. A pre-operative anterior posterior (AP) radiograph of
the pelvis was obtained from all patients within 6 months
of surgery. In order to standardise readings all films were
examined by one of three observers within the co-ordinat-
ing centre (Bristol) who undertook training sessions
together. These three observers all read 20 randomly
selected films on two occasions, in a random order, to test
their inter- and intra-rater reliability using Kappa scores.
They collected data on the hip to be operated on, includ-
ing the standard K&L grade (0–4) [19] and the intra-artic-
ular pattern of disease distribution (supero-lateral,
supero-medial, medial or concentric) and whether the hip
disease appeared hypertrophic (excessive osteophytes and
new bone formation) or atrophic (extensive bone loss).
As most of the radiographs showed advanced OA, we
divided K&L grades 3 and 4 further by adding data from
the individual scores of joint space narrowing and bone
attrition (assessed using the OARSI atlas – [20]). A K&L
grade 3 radiograph with joint space narrowing (grade 1 on
the OARSI atlas) was graded 3a, those with more severe
joint space narrowing (OARSI atlas grade 2) 3b. Similarly,
a K&L grade 4 radiograph (which has complete loss of
joint space, graded 3 on the OARSI atlas) was divided into
4a if there was no bone attrition seen, either in the femur
or acetabulum, and 4b if there was any bone attrition
noted in any part of the joint.
Database management and statistical analysis
Each centre was given 18 months to collect data. A 'Micro-
soft Access' database was set up in Bristol where all patient
data was entered and checked by trained staff. In 2006,
when the study had almost been completed and the data-
base was about to be closed, the analysis plan was agreed
and some remaining missing data obtained from partici-
pants. The database was then closed and a professional
database manager carried out routine data cleaning.
Stata 9.2 was used for all statistical analyses (Stata Corp.,
College Station, TX). The main outcomes in the analysis
were the three WOMAC subscale scores (pain, stiffness,
function) and the combined total WOMAC score. Expo-
sure variables considered in analyses were: Age (< 50, 50–
69, 70+), Gender, Obesity (not obese [BMI < 30], obese
[BMI 30–39], morbidly obese [BMI > 40]), EmploymentPage 3 of 12
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after leaving school (none, diploma or equivalent, degree,
postgraduate degree), ASA status (1, 2, 3, 4), and Kellgren
& Lawrence grade (0, 1, 2, 3, 4) of the hip operated on.
Univariate linear regression analysis was performed to
explore the association between the outcome with each
exposure, and a multivariate regression analysis then car-
ried out to control for confounders. The distribution of
WOMAC scores was assessed to examine the assumption
of normality. Wald tests were used to explore linear
trends, by fitting models with the variable as a score. To
assess for non-linear trends, likelihood ratio tests were
used, comparing a model with a categorical variable to
that with the variable as a score. Effect modification was
considered using likelihood ratio tests to examine for
interaction between age, sex and obesity.
Results
1. The cohort and demography of patients included in the 
analysis
A total of 1520 patients were entered from the 20 centres,
an average of 76 patients/centre (range 41–167) (Table 1).
Scrutiny of the data showed that 193 cases needed to be
omitted because of protocol violations. The most com-
mon violation was the collection of some of the 'baseline'
patient-related information post-operatively (182) and in
a further 11 cases it was unclear which hip had been oper-
ated on and at a EUROHIP group meeting in 2006 it was
agreed that these cases should be omitted from the analy-
sis. The demographic data analysed is therefore on a total
of 1327 cases (87%). Unless otherwise stated, all data pre-
sented here refer to these 1327 cases.
In order to explore the data for differences within Europe,
the participating centres were grouped into 5 regions,
Table 1: EUROHIP Participating orthopaedic centres of excellence, and the number of patients entered into the cohort study 
reported here.
Country City Patients entered
Austria Innsbruck 119
Austria Vienna 44
Finland Helsinki 48
France Paris 46
Germany Dresden 160
Germany Hamburg 167
Germany Heidelberg 47
Germany Magdeburg 49
Germany Ulm 152
Hungary Szeged 70
Iceland Akyreyri 79
Italy Turin 66
Poland Warsaw 50
Spain Madrid 53
Sweden Helsingborg 41
Sweden Karlshamm 70
Switzerland Aarau 52
Switzerland Zurich 60
UK Bristol 97
UK Dundee 50
These centres were divided into regional groups as shown below (see text)
Region Patients in cohort
(1520)
Patients in analysis
(1327)
Austria and Switzerland 275 242
Germany 575 524
Hungary/Poland 120 97
Spain/Italy/France 165 113
Sweden/Iceland/Finland 238 208
UK 147 143Page 4 of 12
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undertake statistical analyses.
While the age range of the included patients was wide, the
majority were in their 6th or 7th decade (Table 2). There
were more women than men and the group was over-
weight. Only 25% were still employed at the time of sur-
gery, the majority had retired because of age, but 8%
reported that they had retired early because of their hip
problems. The patients were generally fairly fit, the ASA
status being recorded as grade 1 or 2 in 79%; only 1% of
patients were ASA status 4.
2. Joint disease and joint replacement
As shown in Table 3, the duration of hip pain was gener-
ally recorded as 1–5 years; only 30% reported that they
had had their hip problem for 6 years or more. Unilateral
hip disease was reported by 32%, a further 13% reported
Table 2: Demographic data
Patients in analysis
(1327)
Excluding missing values
Age groups:
< 35 6 (0.5%) 6 (0.5%)
35–44 46 (3.5%) 46 (3.5%)
45–54 154 (11.6%) 154 (11.9%)
55–64 373 (28.1%) 373 (28.7%)
65–74 456 (34.4%) 456 (35.1%)
75–84 245 (18.5%) 245 (18.9%)
85+ 18 (1.4%) 18 (1.4%)
Missing 29 (2.2%)
Age (mean, SD) 65.7, 10.9
Sex:
Male 559 (42.1%) 559 (44.1%)
Female 708 (53.4%) 708 (55.9%)
Missing 60 (4.5%)
BMI groups:
Underweight (< 18.5) 2 (0.2%) 2 (0.2%)
Normal (18.5 to < 25) 359 (27.1%) 359 (29.3%)
Overweight (25 to < 30) 568 (42.8%) 568 (46.4%)
Obese (30 to < 40) 281 (21.2%) 281 (22.9%)
Morbidly Obese (40+) 15 (1.1%) 15 (1.2%)
Missing 102 (7.7%)
BMI (mean, SD) 27.5, 4.4
Employment status:
Employed 325 (24.5%) 325 (25.1%)
Retired 740 (55.8%) 740 (57.2%)
Unemployed 31 (2.3%) 31 (2.4%)
Retired Early 105 (7.9%) 105 (8.1%)
Voluntary work 5 (0.4%) 5 (0.4%)
Housework 88 (6.6%) 88 (6.8%)
Missing 33 (2.5%)
Qualifications after leaving school:
Postgraduate degree 52 (3.9%) 52 (4.5%)
University degree 149 (11.2%) 149 (12.9%)
College diploma, or equivalent 371 (28.0%) 371 (32.2%)
None 581 (43.8%) 581 (50.4%)
Missing 174 (13.1%)
ASA status:
1 209 (15.8%) 209 (17.8%)
2 719 (54.2%) 719 (61.2%)
3 237 (17.9%) 237 (20.2%)
4 10 (0.8%) 10 (0.9%)
Missing 152 (11.5%)
Caring for someone else:
Yes 234 (17.6%) 234 (18.1%)
No 1061 (80.0%) 1061 (81.9%)
Missing 32 (2.4%)Page 5 of 12
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but the majority (54.6%) had involvement of other joints,
and many had undergone previous surgery on other joints
(mostly the other hip or the knees). The right hip was
operated on more often than the left, and the cemented
type of prosthesis was used most commonly.
3. Radiographic findings
The inter-rater reliability scores (kappa statistic) for the
K&L grades ranged from 0.43 to 0.68, indicating a high
degree of agreement between observers. Intra-rater kappa
scores ranged from 0.63 to 0.89. Of the 1327 people
included in the analyses, radiographs of the operated hip
were only available for reading in 1107 cases (610 right
side and 497 left), and the readers only felt able to assign
a reliable K&L score to 1051 films, because of technical
problems or the severity of pathological changes.
Results for the conventional K&L scoring were grade 0 or
1 – 12 cases (1%), grade 2 – 32 (2.4%), grade 3 – 510
(38.4%), grade 4 – 497 (37.5%), (missing data in 276
cases). We differentiated those with K&L grade 3 or 4 fur-
ther, as described in the methods section. Of the 510 with
grade 3 OA, only 69 had mild joint space narrowing, the
remainder having extensive loss of joint space. Of the 497
Table 3: Status of hip and other joint disease, and type of prosthesis used
Patients in analysis
(1327)
Excluding missing values
Years of reported pain in the hip to be replaced:
< 1 141 (10.6%) 141 (10.7%)
1–2 374 (28.2%) 374 (28.5%)
3–5 403 (30.4%) 403 (30.7%)
6–8 147 (11.1%) 147 (11.2%)
9–12 95 (7.2%) 95 (7.2%)
13–15 49 (3.7%) 49 (3.7%)
> 15 105 (7.9%) 105 (8.0%)
Missing 13 (1.0%)
Arthritis in other joints:
One hip only 416 (31.4%) 416 (32.4%)
Both hips only 167 (12.6%) 167 (13.0%)
Hips(s) & other peripheral joints 701 (52.8%) 701 (54.6%)
Missing 43 (3.2%)
Hip joint being replaced:
Right 724 (54.6%) 724 (54.6%)
Left 603 (45.4%) 603 (45.4%)
Type of prosthesis used:
Hybrid 246 (18.5%) 246 (19.2%)
Cemented 542 (40.8%) 542 (42.3%)
Uncemented 493 (37.2%) 493 (38.5%)
Missing 46 (3.5%)
Surgery on other joints in the past:
Yes 595 (44.8%) 595 (45.4%)
No 716 (54.0%) 716 (54.6%)
Missing 16 (1.2%)
K&L radiographic scores with the split into 3a and b and 4a and b s described.Figu e 1
K&L radiographic scores with the split into 3a and b 
and 4a and b as described.
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had evidence of bone attrition in either the acetabulum or
femoral head (Figure 1).
The commonest recorded pattern of the intra-articular
pattern of distribution of the OA radiographic changes
was superolateral (44.3%), the other patterns, in order of
frequency being superomedial (23.5%), medial (19%)
and concentric (9.1%). 62 hips (5.9%) were thought to
show hypertrophic changes and 102 (9.8%) atrophic fea-
tures.
4. WOMAC scores
Total WOMAC scores were available in 94% of the 1327
patients included in this analysis and followed a normal
distribution (Table 4, Figure 2). While the majority of the
patients coming to hip replacement had WOMAC scores
of 40 or more, a number of patients had relatively low
total scores, indicating quite mild pain and disability.
Overall pain scores were lower than the stiffness or func-
tion domain scores.
5. Associations between demographic features and severity 
of joint disease
We looked for associations between the total WOMAC
scores and age, sex, handedness, BMI, occupational and
educational status, ASA status and the K&L score (Table
5). We carried out the same analysis for the WOMAC pain
score domain alone, and obtained very similar results
(data not shown). It is apparent that higher scores (worse
disease) were present in older subjects, women, those
with obesity, those with higher ASA status, those who had
retired early, and most strikingly, those with no educa-
tional qualifications after leaving school. Radiographic
scores showed no correlation with WOMAC scores.
We then looked specifically at those with low pain scores
(20 or less) in relation to their age and K&L radiographic
status (Table 6)
Finally, we examined the WOMAC total score data to see
if there were any obvious differences in scores in the 5 dif-
ferent European regions (Table 7). There were wide varia-
tions in each European region, with the trends towards
the highest scores in the Eastern Europe grouping (Hun-
gary and Poland) and lowest scores in Austria/Switzerland
and the UK. However, there was no evidence to suggest
that patients from any one particular region or centre were
very different from those of the whole group presented
above (data not presented).
Discussion
This large cohort study of patients with hip joint OA com-
ing to primary total hip joint replacement surgery in Euro-
pean orthopaedic centres, shows that disease severity
varies greatly at the time of surgery, indicating that there is
no consensus on how 'bad' the patient's diseases should
be to warrant surgery. The variation was much wider for
symptoms than for radiographic changes, and one of the
striking findings from the cohort is the absence of any
relationship between the two. Other key findings are that
the severity of symptoms at the time of surgery is associ-
ated with differences in age, sex, weight, general health,
employment status and educational status. These varia-
tions appear to be present throughout Europe, and not
dependent on individual centres.
The demography of our cohort was as expected. The aver-
age age of 69, predominance of retired people, greater
numbers of women than men, and slightly raised mean
BMI are all in accord with other groups of patients coming
to hip replacement [21,22]. Similarly, the wide age ranges
operated on is in keeping with other data suggesting a
trend to surgery being undertaken on more older people
[3]. The majority of our cohort had disease of other joints
(predominantly the other hip and the knees) but that they
were otherwise relatively fit: very few had an ASA score of
3 or 4. The location of the hip OA is also in accord with
previous descriptions, with a predominance of supero-lat-
eral or supero-medial disease [23]. One feature of the
cohort that did surprise us was the relatively short history
of pain in the joint to be operated on: 70% of those for
whom we have this information reported 5 years or less of
joint pain, and only 12% said that they had suffered for 12
years or more. This suggests that the majority of cases
coming to surgery progress fairly rapidly.
We used standard, validated instruments to assess disease
severity. The WOMAC is one of the most commonly used
disease specific measures, which assesses pain, stiffness
and function [16]. One of its problems is the fact that the
disability domain, which dominates the total score, can-
not differentiate between disability due to a single joint,
or that caused by disease in other joints (common in our
Table 4: Summary of WOMAC scores
Pain (n = 1255) Stiffness (n = 1266) Function (n = 1253) Total WOMAC (n = 1243)
Mean (SD) 55.4 (17.8) 60.5 (20.7) 60.1 (16.7) 59.2 (16.1)
Median (IQR) 55 IQR (45–65) 63 IQR (50–75) 60 IQR (50–72) 59.4 IQR (49.0–70.8)
Legend: SD = standard deviation; IQR = interquartile range.Page 7 of 12
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ple should have a total WOMAC score of 39 or more to be
considered for joint replacement [24], but 155 patients
(12.5%) of our cohort had a WOMAC score of 40 or less,
and 16 patients (1.3%) had total WOMAC scores of 20 or
less, which would generally be considered to be indicative
of very mild disease. The variation in WOMAC scores
shown in Figure 2 is striking. The K&L score is the oldest
and most widely used index of radiographic severity of OA
[19]. One of its many problems is lack of discrimination
and a 'ceiling effect', as established OA can only be scored
grade 3 or 4 [25]. We attempted to get round this problem
by modifying it so that we have 4 grades of severity of
established disease – 3a, 3b, 4a, and 4b. In contrast to the
wide variation in the clinical severity of the disease in our
cohort, it is clear that the vast majority had severe radio-
graphic changes. This raises concerns that the radio-
graphic findings may be having an undue influence on
surgical decision-making. It is not clear if radiographic
severity has an impact on the postoperative outcome, and
if so, which radiographic features are most predictive,
there being some conflicting findings amongst recent
publications on this topic [26-28]. Follow-up of our
cohort should contribute to this debate. In this context it
is again interesting to note the lack of any significant rela-
tionship between the clinical severity on the WOMAC
score and the radiographic severity of the disease. It is well
known from epidemiological studies that while radio-
graphic OA is a clear risk factor for symptoms, the correla-
tion between x-ray changes and symptoms is weak, and
that some people with severe x-ray changes of OA remain
asymptomatic 29,30. However, the relationship between
x-ray changes and symptoms in people with severe arthri-
tis coming to surgery has not been studied extensively,
and doctors find it hard to believe that there is not some
relationship when the disease is severe. We believe that
our finding of no association between x-rays and symp-
toms in this patient group reinforces the need to assess
patients on the basis of the impact of the condition on
their lives, and not on x-ray severity, when considering
them for surgery.
Some of our data on the determinants of the variation in
the severity of pain and disability at the time of surgery are
worrying. Similar sex differences have been found in sev-
eral other studies of surgical interventions (women always
having more severe disease at the time of surgery than
men), and remain largely unexplained [24]. The fact that
those who were more unfit (higher ASA status) or more
obese, had more severe symptoms than average before
they were operated on, is also neither a new nor a surpris-
ing finding. However, the strong association with both
employment status and educational status are new find-
ings. There are several possible explanations for an associ-
ation between socio-economic status and surgery,
including access and willingness to undergo surgery, as
well as bias amongst health care professionals, we believe
this inequality needs further investigation.
Histogram of distribution of total WOMAC scoreFigure 2
Histogram of distribution of total WOMAC score.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0
50
10
0
15
0
20
0
Fr
e
qu
en
cy
0 20 40 60 80 100
WOMAC score (normalised)Page 8 of 12
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:19 http://www.biomedcentral.com/1471-2474/10/19Our initial exploration of the data to find out if the varia-
tions in severity observed, and their determinants, are
dominated by events in a single region of Europe, or sin-
gle centres (data not shown) suggests that these findings
are fairly consistent across all countries and centres stud-
ied. However, further examination of the data centre by
centre is being undertaken. The multi-centre, multi-coun-
try nature of the cohort is both a strength and a weakness.
The strength is that it will allow us to examine differences
in different parts of Europe, the weakness is that the huge
variations in the health care systems between, for exam-
ple, northern and eastern Europe, introduce another
source of variation that has nothing to do with the
patients' need for surgery.
This cohort study has other strengths and limitations. Its
strengths include the relatively large number of patients
involved, use of validated outcome measures, and relative
paucity of missing data. Limitations include the fact that
we do not know how representative the cohort is, as it
Table 5: Results of linear regression analysis for Total WOMAC score
Univariate Multivariate
Mean WOMAC score (95%CI) Mean WOMAC score (95%CI)
Age groups:
< 50 56.8 (53.8, 59.8) 58.4 (54.7, 62.1)
50–69 58.2 (57.0, 59.4) 57.5 (56.0, 59.0)
70+ (reference) 61.0 (59.5, 62.5) 61.0 (59.2, 62.8)
P for trend 0.002 0.18
P for nonlinear trend 0.51 0.04
Sex:
Male (reference) 56.1 (54.7, 57.4) 55.7 (54.1, 57.3)
Female 61.5 (60.3, 62.7) 61.6 (60.1, 63.1)
Obesity:
Not obese (reference) 58.2 (57.1, 59.2) 57.5 (56.2, 58.8)
Obese 62.9 (61.0, 64.8) 62.5 (60.2, 64.7)
Morbidly Obese 69.6 (61.0, 78.1) 67.2 (57.6, 76.7)
P for trend < 0.001 0.028
P for nonlinear trend 0.68 0.81
Employment status:
Employed 55.9 (54.1, 57.7) 56.7 (54.6, 58.9)
Retired (reference) 59.6 (58.4, 60.8) 58.8 (57.3, 60.2)
Retired Early 65.9 (62.8, 69.0) 65.3 (61.5, 69.1)
Other 59.8 (56.9, 62.8) 59.6 (55.9, 63.3)
Qualifications after leaving school:
Postgraduate degree (reference) 49.3 (44.9, 53.7) 48.9 (43.3, 54.6)
University degree 54.0 (51.4, 56.6) 53.8 (50.8, 56.7)
College diploma, or equivalent 56.4 (54.8, 58.1) 56.9 (54.9, 58.9)
None 62.1 (60.8, 63.4) 62.2 (60.7, 63.8)
P for trend < 0.001 < 0.001
P for nonlinear trend 0.31 0.96
ASA status:
1 55.5 (53.3, 57.7) 53.2 (50.5, 55.9)
2 (reference) 58.7 (57.5, 59.9) 58.4 (57.0, 59.8)
3 65.6 (63.4, 67.7) 64.6 (62.2, 67.1)
4 59.3 (48.3, 70.3) 54.7 (40.3, 69.0)
P for trend < 0.001 < 0.001
P for nonlinear trend 0.042 0.06
Kellgren & Lawrence Grade:
0 60.1 (47.4, 72.8) 53.6 (37.0, 70.1)
1 70.7 (56.7, 84.6) 77.1 (60.6, 93.7)
2 55.7 (50.2, 61.2) 55.4 (49.4, 61.4)
3 58.0 (56.5, 59.4) 58.4 (56.8, 60.0)
4 (reference) 59.9 (58.5, 61.4) 59.4 (57.8, 61.0)
P for trend 0.16 0.66
P for nonlinear trend 0.12 0.14
The square of the correlation coefficient (R-squared) in the multivariate model is 0.164, so the variables included in the regression model account 
for 16.4% of the variation in the total WOMAC scorePage 9 of 12
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selection of orthopaedic centres, and the fact that we do
not know how many patients were excluded from the
study in each centre, or the reasons for exclusion. In addi-
tion, we do not know which potential patients might have
been triaged out of the system before being able to see a
surgeon, or how many were not put on the waiting list for
surgery. In other words, we do not know whether the
patients in our cohort are truly representative of those in
need of a THR in the community. It is known that the will-
ingness of patients to undergo surgery determines the uti-
lisation of THR [31], and it is likely that this varies in
different European countries.
There are no clear indications for THR. Consensus state-
ments simply emphasise pain due to hip disease and func-
tional impairment, in spite of adequate non-surgical
treatment [4,9]. However, clinical practitioners are aware
of various other reasons for undertaking or delaying a hip
replacement, including age and weight, the social role of
the patient (as a carer for example), their psychological
status, and the presence or absence of any co-morbidities
that might affect surgery or its outcome. In addition, sur-
geons are aware of the importance of the motivation and
expectations of their patients when they undertake sur-
gery. There is an increasing trend for those who pay for
surgical interventions, such as total hip replacement, to
want to use simple scoring systems in order to 'triage'
patients as suitable or unsuitable for surgery. But simple
scoring systems, such as the total WOMAC, cannot
account for subtleties of the sort noted, and these are cru-
cial to appropriate decision making. It has recently been
suggested that a different approach, using the concept of
the 'capacity to benefit' from a total joint replacement
might be used instead of simple scoring systems [7]. This
approach provides surgeons and patients with informa-
tion on the likely risk of adverse events, as well as the
likely degree of benefit, from which to make the judgment
on suitability of surgery. Our data show clearly that if a
score of severity of pain or function were used to assess
suitability for surgery, many patients who are currently
being operated on might not be allowed an operation.
One of the aims of the 'EUROHIP' consortium is to
explore this conundrum further, with more exploration of
these and other data to help us understand when it is most
appropriate to undertake a hip replacement.
Conclusion
This large prospective cohort study of patients coming to
primary total hip replacement for primary osteoarthritis
of the hip has shown that the severity of the disease varies
widely at the time of surgery. The pre-operative scores on
the WOMAC instrument, a widely used measure of oste-
oarthritis severity that assesses pain, stiffness and func-
tion, show that many of the patients appeared to have
relatively mild disease, whereas others are very severely
affected. In contrast, the radiographic findings showed
that almost all patients coming to surgery had severe
structural changes in the affected hip. There was no corre-
lation between clinical severity and radiographic severity.
We interpret these findings as follows. First, we believe
that the data indicate that surgeons require significant
structural changes to be present on the radiographs of
their patients before they are willing to suggest that hip
replacement is advisable. Second, these data show that
simple scoring systems of pain and disability, such as the
WOMAC, should not be used to define thresholds for sur-
gical intervention. The lack of correlation between radio-
graphic severity and clinical severity on the WOMAC
suggests that the decision needs to be based on patient-
Table 6: Number of people with low pain scores by age and K&L 
grade
WOMAC Pain score
0–20 21–100
Total: 46 (3.7%) 1209 (96.3%)
Age groups:
< 50 2 (1.8%) 108 (98.2%)
50–69 31 (4.6%) 641 (95.4%)
70+ 13 (2.9%) 435 (97.1%)
Kellgren & Lawrence Grade:
0 0 (0.0%) 6 (100.0%)
1 0 (0.0%) 6 (100.0%)
2 2 (6.3%) 30 (93.8%)
3 15 (3.1%) 467 (96.9%)
4 21 (4.5%) 451 (95.6%)
Table 7: Summary of total WOMAC scores by region (Not been adjusted for potential confounders)
Region: Mean (SD) Median (IQR) Range
Austria and Switzerland 54.1 (17.2) 55.7 IQR (42.7 – 64.6) 11.5 – 97.9
Germany 58.9 (16.2) 59.4 IQR (47.9 – 70.8) 2.1 – 100.0
Hungary/Poland 67.8 (14.8) 66.7 IQR (58.3 – 76.0) 16.7 – 100.0
Spain/Italy/France 61.5 (14.4) 60.4 IQR (52.2 – 71.9) 12.5 – 93.8
Sweden/Iceland/Finland 60.7 (16.3) 61.5 IQR (51.0 – 71.9) 16.7 – 99.0
UK 56.6 (12.1) 58.3 IQR (48.4 – 65.1) 26.0 – 75.0
Legend: SD, standard deviation; IQR, interquartile range.Page 10 of 12
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BMC Musculoskeletal Disorders 2009, 10:19 http://www.biomedcentral.com/1471-2474/10/19related variables rather than the x-ray, and those variables
should include the degree of pain and disability. How-
ever, a large number of other aspects of the patients' lives
need to be considered before surgery is undertaken,
including their psychological status, their motivation and
expectations, roles in society and social circumstances. We
believe that the patients enrolled into this cohort study
were being operated on for these complex reasons, and
that this explains the huge variation seen in pre-operative
WOMAC scores.
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